Startup Evvy raises $40M to accelerate precision diagnostics and medicine for women’s health

AI startup Evvy has closed a $40 million Series B funding round led by Catalio Capital Management. New investors include Muse Capital, Alumni Ventures, Rethink Impact, and the U.S. Fertility Innovation Fund. The company intends to use this capital to scale its precision diagnostics and care platform, focusing on enhancing women's healthcare. Additionally, Evvy aims to further women's health research by utilizing vaginal microbiome data to accelerate the development of precision medicine for women.